Case File
efta-efta00874307DOJ Data Set 9OtherFrom: Thomas Turrin <
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00874307
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Thomas Turrin <
To: Jeffrey Epstein [email protected]>
CC: Eileen Alexanderson
Subject: RE: Re:
Date: Mon, 22 Apr 2013 14:29:30 +0000
Inline-Images: image001.png; image002jpg; image003jpg
Jeffrey,
Rounding is actually the only reason..in dividing among the four trusts.
From: Jeffrey Epstein [mailtoleevacation@gmalLoom]
Sent: Monday, April 22, 2013 9:34 AM
To: Thomas Turrin
Cc: Eileen Alexanderson
Subject: Re:
Why are they different at all?
On Monday, April 22, 2013, Thomas Turrin wrote:
Jeffrey,
The reason for the slight differences is that the K-1's flowing from the grantor trusts have very slight differences in
amounts..probably due to rounding.
The amounts as reported tie to the K-1's flowing from the grantor trusts.
Best,
Tom
THOMAS TURRIN, CPA
Partner
Rairh Fritha m lter & Co. LLP
New York. New York 10018
Email:
Website: www.rem-co.com
From: Eileen Alexanderson [mailto:
Sent: Monday, April 22, 2013 8:29 AM
To: Thomas Turrin
Subject: FW:
EFTA00874307
From: Jeffrey Epstein [mailto:jeevajamin
Sent: Monday, April 22, 2013 7:46 AM
To: Eileen Alexanderson
Subject:
can you ask tom why on schedules on 2011 tax returns like page 31, the trust apmounts are different by a few
dollars???
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
CONFIDENTIALITY STATEMENT: The information contained in this electronic communication, including any and all attachments and enclosures, may be
privileged and is strictly confidential, intended solely for the use of the person(s) identified above to receive this communication. If you are not the person(s)
identified above to receive this communication, you are hereby notified that you may not disclose print, copy, disseminate, or otherwise use the information
contained herein. If you are an employee or agent of the person(s) identified above to receive this communication and. as such, you have been authorized to deliver
EFTA00874308
this communication to such person(s), you may disclose, print. copy. disseminate. or otherwise use the information contained in this communication solely for the
purpose of such delivery. Unauthorized interception andfor use of this communication areas strictly prohibited and may be punishable by law. II you have received
this communication in error. please reply and notify the sender (only) of that fact and delete the communication. including any and all attachments and enclosures.
from your computer or other electronic device on which you may have received this communication.
CIRCULAR 230 DISCLOSURE:
To insure compliance with requirements imposed by the Internal Revenue Service. we inform you that any tax advice contained in this communication (including any
and all attachments), unless expressly stated otherwise, was not intended or written to be used and cannot be used for the purpose of (i) avoiding tax-related
penalties imposed by the Internal Revenue Code or (ii) promoting, marketing. or recommending to another party any transaction(s) or tax-related mattor(s)
addressed herein. This communication may not be forwarded (other than to the addressee(s) identified above) without our express written consent.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00874309
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.